Related Experiment Videos
Nutrition support for bone marrow transplant patients
1c/o Cochrane Pain, Palliative and Supportive Care Group, Churchill Hospital, Old Road, Oxford, UK, OX3 7LJ. smmurray@ich.ucl.ac.uk
The Cochrane Database of Systematic Reviews
|June 22, 2002
Summary
Parenteral nutrition (PN) with glutamine may reduce hospital stays and infections in bone marrow transplant patients. However, more data is needed to compare PN with enteral nutrition (EN).
Area of Science:
- Oncology
- Gastroenterology
- Nutrition Science
Background:
- Bone marrow transplantation (BMT) treatments can cause malnutrition due to poor appetite, mucositis, and gastrointestinal failure.
- Parenteral nutrition (PN) is a common support but increases infection risk.
- Enteral nutrition (EN) and glutamine supplementation are alternatives, but their comparative efficacy is unclear.
Purpose of the Study:
- To determine the efficacy of enteral nutrition (EN) or parenteral nutrition (PN) for patients undergoing bone marrow transplantation.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) comparing nutrition support methods in BMT patients.
- Searched Cochrane Library, MEDLINE, EMBASE, and CINAHL up to 2000.
- Extracted data on patient characteristics, adverse effects, neutropenia, body weight changes, graft-versus-host disease, and survival.
Main Results:
- Glutamine mouthwash reduced neutropenia duration (p=0.009).
- PN with glutamine decreased hospital stay (p=0.00004) and positive blood cultures (p=0.006) compared to standard PN.
- PN was associated with higher line infection rates than IV fluids (p=0.0002).
- No evaluable data existed to compare PN directly with EN.
Conclusions:
- The comparative effectiveness of EN versus PN in BMT patients remains unevaluated due to insufficient data.
- PN with glutamine shows promise for earlier hospital discharge and fewer infections than standard PN.
- PN with glutamine is recommended for patients with gastrointestinal failure unable to tolerate EN.